ARE N-of-1 Trials an Economically Viable Option to Improve Access to Selected High Cost Medications? The Australian Experience
Paul A. Scuffham, Michael J. Yelland, Jane Nikles, Eva Pietrzak, David WilkinsonVolume:
11
Year:
2008
Language:
english
Pages:
13
DOI:
10.1111/j.1524-4733.2007.00218.x
File:
PDF, 271 KB
english, 2008